Michael J. Bly

469 total citations
12 papers, 372 citations indexed

About

Michael J. Bly is a scholar working on Psychiatry and Mental health, Physiology and Molecular Biology. According to data from OpenAlex, Michael J. Bly has authored 12 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in Michael J. Bly's work include Bipolar Disorder and Treatment (4 papers), Diet and metabolism studies (3 papers) and Inflammatory Bowel Disease (2 papers). Michael J. Bly is often cited by papers focused on Bipolar Disorder and Treatment (4 papers), Diet and metabolism studies (3 papers) and Inflammatory Bowel Disease (2 papers). Michael J. Bly collaborates with scholars based in United States. Michael J. Bly's co-authors include Vicki L. Ellingrod, Tyler Grove, Gregory W. Dalack, Kyle J. Burghardt, Stephan F. Taylor, Rodica Pop‐Busui, Robert D. Brook, Sebastian Zöllner, Simon J. Evans and J. Richard Pilsner and has published in prestigious journals such as Gastroenterology, Schizophrenia Research and Molecular Pharmaceutics.

In The Last Decade

Michael J. Bly

12 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Bly United States 9 157 99 99 66 60 12 372
Chin Cheng Taiwan 10 87 0.6× 94 0.9× 142 1.4× 82 1.2× 15 0.3× 13 396
Richard Bergstrom United States 10 159 1.0× 54 0.5× 58 0.6× 39 0.6× 12 0.2× 16 460
Valerie Powell Canada 10 217 1.4× 39 0.4× 50 0.5× 40 0.6× 23 0.4× 18 321
Tanya J. W. McDonald United States 9 81 0.5× 85 0.9× 309 3.1× 72 1.1× 20 0.3× 14 358
S D'Iddio Italy 13 33 0.2× 171 1.7× 141 1.4× 72 1.1× 32 0.5× 22 506
Debby Postulart Netherlands 9 168 1.1× 43 0.4× 184 1.9× 42 0.6× 25 0.4× 15 429
Nabeel Saif United States 8 74 0.5× 44 0.4× 95 1.0× 41 0.6× 27 0.5× 13 272
Mohammad‐Reza Khatami Iran 12 49 0.3× 41 0.4× 71 0.7× 32 0.5× 12 0.2× 23 394
Brittany Simpson United States 7 62 0.4× 133 1.3× 139 1.4× 12 0.2× 34 0.6× 27 374
Sedef Gidener Türkiye 13 124 0.8× 104 1.1× 55 0.6× 103 1.6× 8 0.1× 50 420

Countries citing papers authored by Michael J. Bly

Since Specialization
Citations

This map shows the geographic impact of Michael J. Bly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Bly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Bly more than expected).

Fields of papers citing papers by Michael J. Bly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Bly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Bly. The network helps show where Michael J. Bly may publish in the future.

Co-authorship network of co-authors of Michael J. Bly

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Bly. A scholar is included among the top collaborators of Michael J. Bly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Bly. Michael J. Bly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bly, Michael J., et al.. (2017). Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder. Clinical Schizophrenia & Related Psychoses. 11(1). 39–48. 23 indexed citations
2.
Yu, Alex, Jason Baker, Ann Fioritto, et al.. (2016). Measurement of in vivo Gastrointestinal Release and Dissolution of Three Locally Acting Mesalamine Formulations in Regions of the Human Gastrointestinal Tract. Molecular Pharmaceutics. 14(2). 345–358. 42 indexed citations
3.
4.
Bly, Michael J., et al.. (2014). Su1081 A Novel Method to Investigate Local Concentrations of Mesalamine in the Gastrointestinal Tract of Healthy Volunteers. Gastroenterology. 146(5). S–367. 3 indexed citations
5.
Bly, Michael J., Jeffrey R. Bishop, Kelan Thomas, & Vicki L. Ellingrod. (2013). P-glycoprotein (PGP) Polymorphisms and Sexual Dysfunction in Female Patients With Depression and SSRI-Associated Sexual Side Effects. Journal of Sex & Marital Therapy. 39(3). 280–288. 18 indexed citations
6.
Bly, Michael J., Stephan F. Taylor, Gregory W. Dalack, et al.. (2013). Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population. Bipolar Disorders. 16(3). 277–288. 79 indexed citations
7.
Lott, Stephen, Paul Burghardt, Kyle J. Burghardt, et al.. (2012). The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia. The Pharmacogenomics Journal. 13(3). 264–271. 37 indexed citations
8.
Burghardt, Kyle J., Rodica Pop‐Busui, Michael J. Bly, et al.. (2012). The Influence of the Brain‐Derived Neurotropic Factor Val66Met ‐Genotype and HMG‐CoA Reductase Inhibitors on Insulin Resistance in the Schizophrenia and Bipolar Populations. Clinical and Translational Science. 5(6). 486–490. 5 indexed citations
9.
Burghardt, Kyle J., J. Richard Pilsner, Michael J. Bly, & Vicki L. Ellingrod. (2012). DNA Methylation in Schizophrenia Subjects: Gender and MTHFR 677C/T Genotype Differences. Epigenomics. 4(3). 261–268. 41 indexed citations
10.
Ellingrod, Vicki L., Stephan F. Taylor, Gregory W. Dalack, et al.. (2012). Risk Factors Associated With Metabolic Syndrome in Bipolar and Schizophrenia Subjects Treated With Antipsychotics. Journal of Clinical Psychopharmacology. 32(2). 261–265. 75 indexed citations
11.
Ellingrod, Vicki L., Stephan F. Taylor, Robert D. Brook, et al.. (2011). Dietary, lifestyle and pharmacogenetic factors associated with arteriole endothelial-dependent vasodilatation in schizophrenia patients treated with atypical antipsychotics (AAPs). Schizophrenia Research. 130(1-3). 20–26. 37 indexed citations
12.
Peng, Ching‐An & Michael J. Bly. (1998). Analysis of xenobiotic bioremediation in a co-immobilized mixed culture system. Biochemical Engineering Journal. 1(1). 63–75. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chin Cheng Breakdown of academic impact, for papers by Richard Bergstrom Breakdown of academic impact, for papers by Valerie Powell Breakdown of academic impact, for papers by Tanya J. W. McDonald Breakdown of academic impact, for papers by S D'Iddio Breakdown of academic impact, for papers by Debby Postulart Breakdown of academic impact, for papers by Nabeel Saif Breakdown of academic impact, for papers by Mohammad‐Reza Khatami Breakdown of academic impact, for papers by Brittany Simpson Breakdown of academic impact, for papers by Sedef Gidener
Rankless by CCL
2026